CIK 0001099800 · Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364316614
- Phone
- 9492502500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Dahl Andrew M. SVP, Corporate Controller | Shares withheld for taxes | −101 | $105.80 | $11K | 14,605.78 |
| 2026-11-10 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +619 | $72.68 | $45K | 40,652.91 |
| 2026-11-10 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $104.25 | $65K | 40,033.91 |
| 2026-11-10 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 2,476 | ||
| 2026-11-09 | Zovighian Bernard J CEO | Option exercise 10b5-1 | +23,100 | $72.68 | $1.7M | 121,945 |
| 2026-11-09 | Zovighian Bernard J CEO | Sale 10b5-1 | −9,184 | $103.39 | $949K | 112,761 |
| 2026-11-09 | Zovighian Bernard J CEO | Sale 10b5-1 | −13,916 | $102.78 | $1.4M | 98,845 |
| 2026-11-09 | Zovighian Bernard J CEO | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −23,100 | 23,100 | ||
| 2026-11-09 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +48,900 | $72.68 | $3.6M | 71,698.25 |
| 2026-11-09 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −48,900 | $103.05 | $5.0M | 22,798.25 |
| 2026-11-09 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −48,900 | 0 | ||
| 2026-10-08 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +619 | $72.68 | $45K | 40,652.91 |
| 2026-10-08 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $85.65 | $53K | 40,033.91 |
| 2026-10-08 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 3,095 | ||
| 2026-09-14 | Markowitz Wayne CVP, JAPAC | Shares withheld for taxes | −568 | $84.37 | $48K | 19,370.56 |
| 2026-09-13 | Dahl Andrew M. SVP, Corporate Controller | Shares withheld for taxes | −253 | $84.37 | $21K | 14,615.41 |
| 2026-09-11 | Markowitz Wayne CVP, JAPAC | Shares withheld for taxes | −355 | $86.77 | $31K | 19,938.56 |
| 2026-09-11 | Chopra Daveen CVP, TMTT, Surgical & IHFM | Shares withheld for taxes | −398 | $86.77 | $35K | 43,926 |
| 2026-09-11 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +619 | $72.68 | $45K | 40,652.91 |
| 2026-09-11 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $87.51 | $54K | 40,033.91 |
Page 1 of 13 · 249 trades